From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 445,711 shares, representing 1.97% for $0.51 million under the buyback announced on January 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4355 USD | -1.69% |
|
+11.44% | -98.40% |
05-21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
05-20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.40% | 8.25M | |
+54.61% | 811B | |
+43.65% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.83% | 246B | |
+2.54% | 225B | |
+13.02% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.